Heat shock protein A12B (HSPA12B) is mainly expressed in endothelial cells and protects against several harmful factors.
First-pass extracted concept
HSPA12B
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
Heat shock protein A12B
Evidence Snippets
Supporting Sources
Linked Claims
Knockdown of HSPA12B aggravates lung pathological injury, inflammatory cytokine expression, myeloperoxidase activity, neutrophil infiltration, pulmonary edema, endothelial apoptosis, and worsens survival after CLP surgery.
Quoted textsource-backed
The administration of HSPA12B siRNA aggravated lung pathological injury, upregulated pro-inflammatory cytokine (e.g., IL-1β, TNF-α, and IL-6) expression, and increased myeloperoxidase activity, neutrophil infiltration, pulmonary edema, and pulmonary endothelial cell apoptosis. Additionally, HSPA12B knockdown worsened survival after CLP surgery.
The protective mechanism of HSPA12B may partly involve inhibition of ERK phosphorylation and caspase-3 activation in vivo and in vitro.
Quoted textsource-backed
The potential protective mechanisms of HSPA12B may involve the inhibition of ERK phosphorylation and caspase-3 activation in vivo and in vitro.
HSPA12B protects vascular endothelial cells against sepsis-induced acute lung injury in mice.
Quoted textsource-backed
HSPA12B protected against sepsis-induced ALI.